The role of the corporate treasury has changed. The credit crisis has resulted in decreased availability of funding, and corporations need to leverage internal cash, minimizing external cash requirements at all times. With the current cost of funding being very high, corporations must have efficient internal funding methods, and global visibility of all available cash to achieve this efficiency. They need to control exposures with counterparties and have good connectivity to all their banks, trading platforms and accounting systems. To reduce their costs and manage risk, corporations need to leverage their use of technology more now than ever before.
More than 200 of the world’s leading corporations rely on treasury solutions from Wall Street Systems. We have the world’s largest global treasury systems practice with more than 75 go-lives each year, 2,000 man years of expertise and many senior industry figures. We have an unrivalled implementation track record. Our solutions deliver effective risk management, control of counterparty exposures, real-time cash flow forecasts, global visibility of cash reserves and seamless connectivity to banks and accounting systems. There are two solutions to choose from:-
Wallstreet Treasury Software as a Service (SaaS) is a best practice, hosted, on-demand corporate treasury solution. It is cost effective and easy to deploy. With seamless integration between best of breed products, it enables the treasurer to take a service based approach to fulfil the global company needs. Clients include Fujitsu, Kellogg’s, Volvo and Nasdaq. Read more
Wallstreet Suite is a highly configurable solution, customised to your specific needs. It delivers unprecedented ROI, with immediate visibility, control and simplified compliance. It supports large payment volumes, parallel accounting (multiple GAAP), multiple in-house banks, integrated payments, risk and treasury within one system, simplifying even the most complex of global corporate treasury operations. Clients include GE, IBM, Toyota, Daimler and Merck & Co. Read more
